Therapy for the treatment of brain tumors, Hodgkin's disease
Created 5 months ago by marykudro

Carmustine falls under the class of medicines named alkylating agents. It acts in order to slow down or inhibit the growth of cancer cells in the body. The carmustine price may depend on a WHO-GDP and ISO certified wholesaler, type of brand (either innovator or generic), and the severity of the disease. Carmustine is prescribed to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma. The recommended dose of Carmustine is most often administered through intravenous (IV, into a vein) infusion. The dosage of Carmustine depends on the recipient's size and the tumor type being treated. Complete blood count of the recipient will be closely monitored prior to and following therapy.